Paclitaxel coated balloon fibroplasty: A more effective treatment for chronic symptomatic lead/catheter related central venous obstruction?
balloon fibroplasty
paclitaxel coated balloon
subclavian venous occlusion
Journal
Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
24
11
2020
revised:
03
01
2021
accepted:
13
01
2021
pubmed:
30
1
2021
medline:
10
8
2021
entrez:
29
1
2021
Statut:
ppublish
Résumé
Central venous occlusion is a common complication following transvenous lead or therapeutic catheter placement that can present either acutely or chronically.
Substances chimiques
Paclitaxel
P88XT4IS4D
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
867-870Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Rooden CJV, Molhoek SG, Rosendaal FR, Schalij MJ, Meinders AE, Huisman MV. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol. 2004;15(11):1258-1262.
Abu-El-Haija B, Bhave PD, Campbell DN, et al. Venous stenosis after transvenous lead placement: a study of outcomes and risk factors in 212 consecutive patients. J Am Heart Assoc. 2015;4(8):e001878.
Stoney WS, Addlestone RB, Alford WC, Burrus GR, Frist RA, Thomas CS. The incidence of venous thrombosis following long-term transvenous pacing. Ann Thorac Surg, 22(2):166-170.
Zou F, Brar V, Worley SJ. Interventional device implantation, Part I: basic techniques to avoid complications: a hands-on approach [published online ahead of print September 18, 2020]. J Cardiovasc Electrophysiol. 2020. https://doi.org/10.1111/jce.14748
Spittell PC, Hayes DL. Venous complications after insertion of a transvenous pacemaker. Mayo Clin Proc. 1992;67(3):258-265.
Tarakji KG, Saliba W, Markabawi D, et al. Unrecognized venous injuries after cardiac implantable electronic device transvenous lead extraction. Heart Rhythm. 2018;15(3):318-325.
Goto Y, Abe T, Sekine S, Sakurada T. Long-term thrombosis after transvenous permanent pacemaker implantation. Pacing Clin Electrophysiol. 1998;21(6):1192-1195.
Worley SJ, Gohn DC, Pulliam RW, Raifsnider MA, Ebersole BI, Tuzi J. Subclavian venoplasty by the implanting physicians in 373 patients over 11 years. Heart Rhythm. 2011;8(4):526-533.
Ji SY, Gundewar S, Palma EC. Subclavian venoplasty may reduce implant times and implant failures in the era of increasing device upgrades. Pacing Clin Electrophysiol PACE. 2012;35(4):444-448.
Kella DK, Isath A, Yasin O, et al. Fibroplasty (venoplasty) to facilitate transvenous lead placement: a single-center experience. J Cardiovasc Electrophysiol. 2020;31(9):2425-2430.
Kitrou PM, Papadimatos P, Spiliopoulos S, et al. Paclitaxel-coated balloons for the treatment of symptomatic central venous stenosis in dialysis access: results from a randomized controlled trial. J Vasc Interv Radiol. 2017;28(6):811-817.
Lookstein RA, Haruguchi H, Ouriel K, et al. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas. N Engl J Med. 2020;383:733-742.
Riley RF, Petersen SE, Ferguson JD, Bashir Y. Managing superior vena cava syndrome as a complication of pacemaker implantation: a pooled analysis of clinical practice. Pacing Clin Electrophysiol PACE. 2010;33(4):420-425.
Bongiorni MG, Burri H, Deharo JC, et al. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. EP Eur. 2018;20(7):1217-1217.
Fu H-X, Huang X-M, Zhong L, et al. Outcome and management of pacemaker-induced superior vena cava syndrome: pacemaker-induced superior vena cava syndrome. Pacing Clin Electrophysiol. 2014;7(11):1470-1476.
Galougahi KK, Petrossian G, Hill JM, Ali Z, et al. Intravascular lithotripsy in cardiovascular interventions. American College of Cardiology. Expert Analysis. J Am Coll Cardiol. 2020;76:2651-2653.
Hill JM, Kereiakes DJ, Shlofmitz RA, et al. Intravascular lithotripsy for treatment of severely calcified coronary artery disease. J Am Coll Cardiol. 2020;76(22):2635-2646.
Massmann A, Fries P, Obst-Gleditsch K, Minko P, Shayesteh-Kheslat R, Buecker A. Paclitaxel-coated balloon angioplasty for symptomatic central vein restenosis in patients with hemodialysis fistulas. J Endovasc Ther. 2015;22(1):74-79.
Kennedy SA, Mafeld S, Baerlocher MO, Jaberi A, Rajan DK. Drug-coated balloon angioplasty in hemodialysis circuits: a systematic review and meta-analysis. J Vasc Interv Radiol. 2019;30(4):483-494.